This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie policy for more information on the cookies we use and how to delete or block them.
PI’s business model has been proven a success with another of its investee companies – Visus Therapeutics™ – raising $US36 ($A47) million in Series A financing.
Sue MacLeman, an experienced and respected leader in Australia’s medtech industry, has joined the Planet Innovation Board as a non-executive director.
Planet Innovation has closed an oversubscribed $9.8 million capital raising to accelerate business growth to meet strong international demand for its manufacturing, product development and digital services.
Lumos Diagnostics, a rapid point-of-care diagnostics company spun out of Planet Innovation, has closed an oversubscribed AU$25 million pre-IPO capital raise, ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing.
Hany Massarany, a renowned leader in the global diagnostics industry, is joining the Planet Innovation Board as a non-executive director.
PI has welcomed two experienced company leaders to the PI Board, with Jonathan Ling appointed Chairman and Jim Fox joining as a non-executive director.
Lumos Diagnostics and RPS Diagnostics have merged to create a full-service point-of-care diagnostic development company and support the international commercialization of FebriDx.
Planet Innovation has strengthened its position as a global player in the commercialisation of technology ventures with the strategic appointment of Teresa Engelhard to the Board of Planet Group Holdings.
A roundup of the latest news and opinions from PI.
At a formal ceremony attended by Australian Federal Assistant Treasurer, Josh Frydenberg, Planet Innovation (PI) has officially revealed its all new centre for Product Development and Manufacturing.
Diagnostics
Life Sciences
Medical Devices
Internet of Things